Event Type
Disclosure
Mandatory
Variant
8-K
. Results of Operations and Financial Condition. On February 11, 2026, Nuvectis Pharma, Inc. issued a press release to provide a corporate update and to announc
. Financial Statements and Exhibits. (d) Exhibits. The following exhibit is furnished herewith: Exhibit Number Description 99.1 Press release issued by Nuvectis